Target intelligence / Profile preview

Salivary proline-rich proteins (PRPs)

Target
PRPs
Molecular classification
Salivary protein, Intrinsically disordered protein, Proline-rich protein family
01

Overview

Salivary proline-rich proteins (PRPs) are a major family of intrinsically disordered proteins that constitute a significant portion of human saliva, particularly from the parotid glands. They are characterized by a high content of proline, glycine, and glutamine residues and are classified into acidic, basic, and glycosylated subclasses. PRPs play a vital role in oral health by forming the acquired enamel pellicle, which protects teeth from acid erosion and regulates bacterial colonization. They also serve as a primary defense against dietary tannins by binding and precipitating these polyphenols, a process that also results in the sensation of astringency. In clinical practice, PRPs are relevant as they interact with oral care agents like chlorhexidine and fluoride, and their levels or genetic variants are used as biomarkers for susceptibility to dental caries and salivary stones. Beyond the oral cavity, the broader proline-rich protein family includes members involved in skin barrier function and systemic signaling, making them a subject of interest for novel therapeutic and diagnostic applications.

Other names
Proline-rich salivary and other proteinsSalivary PRPsAcidic proline-rich proteinsBasic proline-rich proteinsGlycosylated proline-rich proteinsPRP family
02

Mechanism of action

Binding and precipitation of dietary tannins to prevent toxicity; formation of a protective enamel pellicle on tooth surfaces; modulation of calcium phosphate crystallization to maintain enamel integrity; providing a reservoir for antimicrobial agents like chlorhexidine.

03

Biological functions

Oral lubricationEnamel pellicle formationCalcium bindingTannin binding and detoxificationAntimicrobial activityInhibition of calcium phosphate precipitation
04

Disease associations

Dental cariesSialolithiasisPeriodontal diseaseSjögren's syndrome
05

Safety considerations

Astringency (sensory side effect)Potential for salivary stone (sialolith) formationDegradation by bacterial or host proteases (e.g., elastase) in disease states
06

Interacting drugs

Chlorhexidine

4 more in the full profile.

07

Biomarkers

Salivary PRP levelsFree proline levels in salivaAcidic PRP phenotypes (e.g., Db allele)

Beyond the preview

Go deeper on Salivary proline-rich proteins (PRPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salivary proline-rich proteins (PRPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call